Found: 14
Select item for more details and to access through your institution.
First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?
- Published in:
- Investigational New Drugs, 2024, v. 42, n. 2, p. 196, doi. 10.1007/s10637-024-01424-4
- By:
- Publication type:
- Article
Optimal timing of hypofractionated stereotactic radiotherapy for epidermal growth factor receptor‐mutated non‐small‐cell lung cancer patients with brain metastases.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2023, v. 19, n. 6, p. 731, doi. 10.1111/ajco.13957
- By:
- Publication type:
- Article
Cranial radiation therapy with hippocampus avoidance in lung cancer treatment: systematic review and meta-analysis.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1268754
- By:
- Publication type:
- Article
Diverse regulated cell death modes predict the immune microenvironment and drug sensitivity in lung adenocarcinoma.
- Published in:
- Journal of Cellular Physiology, 2023, v. 238, n. 11, p. 2570, doi. 10.1002/jcp.31109
- By:
- Publication type:
- Article
Involved-field irradiation or elective-nodal irradiation in neoadjuvant chemoradiotherapy for locallyadvanced esophageal cancer: comprehensive analysis for dosimetry, treatment-related complications, impact on lymphocyte, patterns of failure and survival.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1274924
- By:
- Publication type:
- Article
Incidence and risk factors of acute kidney injury in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1173952
- By:
- Publication type:
- Article
Epigenetic reprogramming in small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1111, doi. 10.20892/j.issn.2095-3941.2022.0343
- By:
- Publication type:
- Article
HIF-1-dependent heme synthesis promotes gemcitabine resistance in human non-small cell lung cancers via enhanced ABCB6 expression.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 6, p. 1, doi. 10.1007/s00018-022-04360-9
- By:
- Publication type:
- Article
Identifying a confused cell identity for esophageal squamous cell carcinoma.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-00946-8
- By:
- Publication type:
- Article
Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.
- Published in:
- Precision Clinical Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1093/pcmedi/pbac005
- By:
- Publication type:
- Article
Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung‐molGPA) in a Chinese cohort: A retrospective study of multiple institutions.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 23, p. 8772, doi. 10.1002/cam4.3485
- By:
- Publication type:
- Article
Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 7, p. 2243, doi. 10.1111/cas.13650
- By:
- Publication type:
- Article
Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 405, p. 1, doi. 10.1126/scitranslmed.aai8710
- By:
- Publication type:
- Article
The Association between TGF-β1 Polymorphisms and Radiation Pneumonia in Lung Cancer Patients Treated with Definitive Radiotherapy: A Meta-Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091100
- By:
- Publication type:
- Article